awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36600800-1CEE2E06-AADD-4452-A27C-E5A6A2D3679E
Q36600800-1CEE2E06-AADD-4452-A27C-E5A6A2D3679E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36600800-1CEE2E06-AADD-4452-A27C-E5A6A2D3679E
Future directions in the treatment of osteosarcoma.
P2860
Q36600800-1CEE2E06-AADD-4452-A27C-E5A6A2D3679E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36600800-1CEE2E06-AADD-4452-A27C-E5A6A2D3679E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38a728b07b9ae29fd1c14fa7fe7e8feaa475f3b7
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.